Search Results
Found 2 results
510(k) Data Aggregation
(176 days)
The "Microjet Crono K" and "Crono go" ambulatory infusion pump device has been designed for use in subcutaneous and intravenous infusion of prescribed liquid medicines.
Canè s.r.l., a company that specializes in the production of ambulatory pumps, has now produced a new generation of compact pumps: Crono K, a perfect combination of high technology and innovative design. The infusion pumps which use normal commercial syringes are inevitably cumbersome and thus difficult to use in everyday life. This provokes in the patients a refuse of the therapy. A special syringe, an integral part of the Crono K allows an efficient reduction of the pump size. In this way, the patients can freely carry out the therapy at any time of the day, even during their everyday life. Patients who have been following a iron chelation therapy for a long time, often experience difficulties in absorbing the drug subcutaneously; this may lead to a catheter occlusion with consequent interruption of the infusion. Crono K has a particular mechanism which pushes directly the rubber syringe piston: so it is possible to reach a thrust force up to 3 times higher with respect to conventional pumps. In case of catheter occlusion, an innovative infusion control system makes it possible to proceed with the infusion automatically and, after the occlusion is eliminated, to complete it. For a better absorption of the drug, Crono K makes the infusion up to 3 times more fractionated with respect to traditional pumps (22 ml per impulse, using a 10/20 ml syringe). Crono K is fitted with a liquid crystal display which shows the time it takes to complete the delivery and battery charge status.
Here's an analysis of the provided information regarding the Microjet Crono K and Crono go ambulatory infusion pumps, focusing on acceptance criteria and the study that proves the device meets them:
Disclaimer: The provided document is a 510(k) summary from 2002, which typically focuses on demonstrating substantial equivalence to a predicate device rather than comprehensive clinical trial results with detailed performance metrics and statistical analyses as might be found in a more recent PMA or extensive clinical study report. Therefore, some of the requested information (like specific effect sizes for MRMC studies or detailed ground truth methodologies) is not explicitly present in this type of submission.
Acceptance Criteria and Reported Device Performance
The provided 510(k) summary primarily demonstrates substantial equivalence to a predicate device (Cadd-Legacy 1 Ambulatory Infusion Pump, K982838) by comparing characteristics and showing that the new device is as safe and effective. It does not explicitly list quantified acceptance criteria with specific performance thresholds (e.g., a "must achieve X% accuracy"). Instead, "acceptance criteria" are implied by the comparison to the predicate device, where the new device must perform at least as well as or similarly to the predicate device in aspects like safety and effectiveness.
1. Table of Acceptance Criteria and Reported Device Performance:
Characteristic | Acceptance Criteria (Implied by Predicate) | Reported Device Performance ("Microjet Crono K" & "Crono go") |
---|---|---|
Intended Use | Subcutaneous and intravenous infusion of prescribed liquid medicines (as per predicate's relevant uses) | Subcutaneous and intravenous only |
Safety | As safe as the predicate device | Bench, EMC, and user testing indicate safety comparable to predicate. |
Effectiveness | As effective as the predicate device | Bench, EMC, and user testing indicate effectiveness comparable to predicate. |
Technological Differences | Minor differences that do not raise new questions of safety or effectiveness | Few technological differences (e.g., battery type, size, weight, capacity, warranty) and no new indications for use. |
Flow/Infusion Control | Reliable infusion without frequent occlusions, or with effective occlusion management (implied by predicate's function) | Particular mechanism for high thrust force (up to 3x higher) to address catheter occlusion; innovative infusion control system to proceed automatically after occlusion is eliminated. Infusion up to 3x more fractionated (22 ml per impulse for 10/20ml syringe) for better absorption. |
Patient Experience/Usability | User-friendly, portable (implied to avoid "refuse of therapy") | Compact size (3" x 1.85" x 1.14", 4.0 oz) due to special syringe; fitted with LCD showing delivery time and battery status. |
Study Proving Device Meets Acceptance Criteria:
The study that proves the device meets the implied acceptance criteria for substantial equivalence consists of bench testing, EMC (Electromagnetic Compatibility) testing, and user testing.
2. Sample Size Used for the Test Set and Data Provenance:
- Sample Size: The document does not specify the sample size for the bench testing, EMC testing, or user testing. These are typically internal validation studies that are summarized to support the 510(k) rather than detailed clinical trial reports with specific patient numbers.
- Data Provenance: The studies were conducted by CANÉ S.r.l. (the manufacturer) in Rivoli-Cascine Vica (Torino), Italy. The data is retrospective in the sense that these tests were performed and summarized to support the 510(k) submission. It's not a prospective, multi-center clinical trial report.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts:
- The document does not provide details on the number of experts, their qualifications, or how ground truth was established specifically for the test sets (bench, EMC, user testing). Such information is generally not required for a 510(k) summary demonstrating substantial equivalence for this type of device. The "user testing" would likely involve medical professionals and/or patients, but their expert role in establishing a formal "ground truth" (as in diagnostic accuracy studies) is not described.
4. Adjudication Method for the Test Set:
- The document does not describe any formal adjudication method for the test sets (bench, EMC, user testing). Adjudication methods like '2+1' or '3+1' are typical in diagnostic imaging studies where consensus among multiple readers is needed to define a ground truth for ambiguous cases. This is not applicable to the types of tests mentioned (bench, EMC, user testing) for an infusion pump.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:
- No MRMC comparative effectiveness study was mentioned or performed as part of this 510(k) submission. MRMC studies are specific to diagnostic devices where human readers interpret medical images or data, and their performance with and without AI assistance is compared. This is not relevant for an infusion pump.
6. Standalone (Algorithm Only) Performance Study:
- While the device itself is an "algorithm" in the sense that it controls infusion, no separate "standalone" algorithm-only performance study (without human-in-the-loop performance), as understood in AI/ML medical devices (e.g., an automated diagnostic algorithm without human oversight), was conducted or reported. The device's performance inherently involves its interaction with a user (loading medication, setting parameters) and patient (receiving infusion). The "bench testing" would evaluate the device's mechanical and electrical functions in a controlled environment, which could be considered an "algorithm-only" performance aspect to some extent, but not in the context of an AI-driven diagnostic or interpretative algorithm.
7. Type of Ground Truth Used:
- For bench testing: The "ground truth" would be established by engineering specifications, known physical principles, and validated measurement techniques. For example, flow rate accuracy would be compared against a known standard, occlusion detection against intentionally induced blockages, and battery life against expected draw under defined conditions.
- For EMC testing: The "ground truth" is established by adherence to international standards and regulatory limits for electromagnetic emissions and immunity (e.g., IEC 60601-1-2 or similar).
- For user testing: The "ground truth" or validation would be based on observed functional success, ease of use, and user feedback compared to the predicate device or established usability principles. This is not a pathology or outcomes data type of ground truth.
8. Sample Size for the Training Set:
- Not applicable / Not specified. This device is an infusion pump, not an AI/ML-based system that uses a "training set" in the computational learning sense. The device's design and functionality are based on engineering principles and prototypes, not on a machine learning training dataset.
9. How the Ground Truth for the Training Set Was Established:
- Not applicable. As the concept of a "training set" for an AI/ML model does not apply here, there is no ground truth established for such a set. The "ground truth" for the device's design and engineering would be based on fundamental scientific and engineering principles, functional requirements, and safety standards.
Ask a specific question about this device
(164 days)
The portable CD4, CD4/20 infusion devices have been designed only for use in subcutaneous infusion of prescribed liquid medicines.
This infusion device has been manufactured since 1978 and has, during all this time, proved to be highly reliable in terms of sturdiness, reliability, accuracy and easy operation. Moreover, it does not require particular maintenance work. Microjet CD4 is a portable, battery-operated infusion device for use with 5 ml and 10 ml syringes (20 ml syringes are used with model CD4/20). A special micromotor actuates mechanical members that transform the motor rotary motion into the pusher linear motion which, in turn, causes the syringe piston to advance. The infusion device operating features enable to make infusions with varying amounts of medicine and different infusion times. During infusion, the motor is controlled by a special electronic circuit with regular pulses; therefore, infusion is carried out by delivering small amounts of medicine repeated with the passing of time.
The provided text describes a 510(k) summary for the Microjet CD4, CD4/20 Ambulatory Infusion Pump. It does not contain information about acceptance criteria or a study proving the device meets said criteria in the context of AI/ML performance. Instead, it focuses on demonstrating substantial equivalence to a predicate device for market clearance.
Therefore, most of the requested information regarding AI/ML device performance metrics, sample sizes for test/training sets, expert qualifications, and ground truth establishment is not present in the provided document.
Here's a breakdown of what can be extracted and what is missing:
1. Table of Acceptance Criteria and Reported Device Performance:
The document describes the device's characteristics and compares them to a predicate device, but it does not specify quantitative acceptance criteria or performance metrics in the way one would for an AI/ML system (e.g., sensitivity, specificity, AUC).
Instead, the "performance" is implicitly deemed acceptable by demonstrating substantial equivalence to a legally marketed predicate device. The characteristics compared are:
Characteristic | Cadd-Legacy 1 (Predicate) | Microjet CD4, CD4/20 (New Device) |
---|---|---|
Intended Use | Intravenous, Intra-arterial, Subcutaneous, Intraperitoneal, Epidural, Intrathecal | Subcutaneous only |
Physical characteristics: | ||
Power Source | 2 AA alkaline batteries, AC Adapter | 9 volt Alkaline battery |
Size | 4.4 x 3.8 x 1.6 in (112x 95x41 mm) | 170 x 70 x 20 mm |
Weight | 13.8 oz (392 grams) | Approximately 220 g (including alkaline battery) |
Capacity | 10 ml | Disposable 5 ml or 10 ml syringes (CD4/20 model accommodates 20 ml syringes) |
Warranty | 1 year | SAME |
The "study" that proves the device meets acceptance criteria is described as "bench, EMC, and user testing," which concluded that the new device is "as safe and effective as the predicate device" and has "few technological differences."
Missing Information (Relevant to AI/ML Performance):
- Specific quantitative acceptance criteria (e.g., accuracy, precision, recall) for AI/ML performance.
- Reported device performance against such criteria.
2. Sample size used for the test set and the data provenance:
- Sample Size: Not specified. The document mentions "bench, EMC, and user testing" but does not quantify the number of units or users involved in these tests.
- Data Provenance: Not specified, other than it being part of internal testing by CANÈ S.r.l. (Italy).
- Retrospective/Prospective: Not specified.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not applicable to this type of device submission. Ground truth, in this context, would relate to the physical and functional performance of the infusion pump itself, not diagnostic interpretations by experts.
4. Adjudication method for the test set:
- Not applicable.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- Not applicable. This is not an AI/ML diagnostic or assistive device.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Not applicable. This is a standalone medical device (infusion pump), not an algorithm.
7. The type of ground truth used:
- The "ground truth" for this device would be established through engineering specifications, laboratory measurements for accuracy and reliability, and possibly usability assessments during user testing. The document refers to "bench, EMC, and user testing data" to support its claims of safety and effectiveness, implying these physical and functional validations served as the basis for comparison.
8. The sample size for the training set:
- Not applicable. This device does not use an AI/ML training set.
9. How the ground truth for the training set was established:
- Not applicable. This device does not use an AI/ML training set.
Ask a specific question about this device
Page 1 of 1